Avalo Therapeutics, Inc. 10-K filing
Filed 2026-03-23 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001534120-26-000011
- Form type
- 10-K
- CIK
- 0001534120
- Primary document
- https://www.sec.gov/Archives/edgar/data/1534120/000153412026000011/avtx-20251231.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Avalo Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $59,000 | - | - |
| Operating Income | $-72.9M | - | - |
| Net Income | $-78.3M | - | - |
| Eps Basic | -5.84 | - | - |
| Eps Diluted | -5.84 | - | - |
| Cash And Equivalents | $15.9M | - | - |
| Total Assets | $116.5M | - | - |
| Total Liabilities | $33.4M | - | - |
| Shareholders Equity | $83.0M | - | - |
| Operating Cash Flow | $-51.5M | - | - |